ROJUZDA

Swiss trademark · 678464 · Word mark · In force

Register entry

Registration number
678464
Application number
58198/2015
Status
In force
Type
Word mark
Filed
Jul 9, 2015
Registered
Sep 29, 2015
Published
Sep 29, 2015
Protected until
Jul 9, 2035
Source
Swissreg

Goods and services

Pharmaceuticals

Préparations pharmaceutiques pour usage dans les domaines de l'oncologie, de l'immunologie et de l'inflammation; préparations pharmaceutiques pour usage dans le traitement des syndromes bêta-thalassémiques et myélodisplastiques, de maladies auto inflammatoires, de maladies auto-immunes, de maladies du sang, de cancers, de l'arthrite, de maladies musculo-squelettiques et de maladies de la peau; préparations pharmaceutiques, notamment médicaments inhibiteurs de cytokines; préparations pharmaceutiques destinées à moduler le système immunitaire.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 3, 2025

    Renewed

    Expiry date
    09.07.2025 → 09.07.2035

    Published in Swissreg on 03.06.2025

  2. Feb 5, 2025

    Holder’s address changed

    Owner
    Celgene Corporation, 86 Morris Avenue, Summit (NJ 07901), USA → Celgene Corporation, Route 206 & Province Line Road, Princeton, New Jersey 08543, USA

    Published in Swissreg on 05.02.2025

  3. Jun 22, 2021

    Agent removed

    Representative
    Kirker & Cie SA, Conseils en Marques, Rue de Genève 122,, Case Postale 153, 1226 Thônex (removed)

    Published in Swissreg on 22.06.2021

  4. Jun 22, 2021

    Agent entered

    Representative
    Troller Hitz Troller, Rechtsanwälte, Schweizerhofquai 2, Postfach, 6002 Luzern

    Published in Swissreg on 22.06.2021

  5. Sep 29, 2015

    Registered

    Published in Swissreg on 29.09.2015

Parties

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.